Cite
HARVARD Citation
Shimoyama, R. et al. (2021). A multi-institutional randomized phase III study comparing weekly carboplatin plus nab-paclitaxel and daily low-dose carboplatin as regimens for concurrent chemoradiotherapy in elderly patients with unresectable locally advanced non-small cell lung cancer: Japan Clinical Oncology Group Study JCOG1914. Japanese journal of clinical oncology. pp. 836-841. [Online].